Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Conference News ESOC 2025

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

Todd Neale

May 22, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

Genetic Risk Score for Endothelial Cell Dysfunction Identifies Patients at Risk

News Daily News

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Michael O'Riordan

February 27, 2025

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Michael O'Riordan

January 23, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ISC 2023

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

Todd Neale

February 14, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

Todd Neale

October 14, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

Advertisement

Risk Factors Present in Nearly All Patients Who Develop CVD

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

May 2025 Dispatch for the CV Team

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

June 2024 Dispatch for the CV Team

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

High Lp(a) Levels Harmful in Patients With and Without ASCVD

February 2024 Dispatch for the CV Team

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

November 2023 News Roundup

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Half-Dose DOAC May Be a Good Post-Watchman Option

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content